Neutralizing HIV Antibodies

Several methods have been utilized to isolate and characterize individual antibodies from the human repertoire and each of these methods has been applied to the generation of broadly neutralizing HIV antibodies. Discover the latest research on neutralizing HIV antibodies.

September 17, 2020
Case Report
Open Access

The initial intravenous treatment of a human immunodeficiency virus-infected child with complicated abdominal tuberculosis

Southern African Journal of HIV Medicine
Anthony K EnimilJames Nuttall
October 2, 2020
Open Access

Neutralizing antibody responses induced by HIV-1 envelope glycoprotein SOSIP trimers derived from elite neutralizers

Journal of Virology
Anna SchorchtRogier W Sanders
October 1, 2020

Kicking the habit - how can we improve the routine care for patients who are well controlled living with HIV?

International Journal of STD & AIDS
M DresserN Premchand
September 17, 2020

HIV-1 Subtype C tier 3 viruses have increased infectivity as compared to tier 2 viruses

AIDS Research and Human Retroviruses
Thandeka MoyoJeffrey R Dorfman
September 18, 2020
Open Access

Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme

JCI Insight
Zachary C ElmoreAravind Asokan
September 26, 2020

High prevalence of sexually transmitted infections in pregnant women living in southern Brazil

Sexually Transmitted Diseases
Nava YeganehJeffrey Klausner
October 8, 2020
Open Access

Use of immunoglobulin-binding bacterial proteins in immunodetection.

BioRxiv : the Preprint Server for Biology
Angel Alberto Justiz Vaillant
October 9, 2020
Open Access

Outbreak of acute hepatitis A associated with men who have sex with men (MSM) in North Sardinia 2017-2018

Journal of Infection in Developing Countries
Riccardo BazzardiIvana Maida
September 22, 2020
Open Access

An Automated Fluorescence-Based Method to Isolate Bone Marrow-Derived Plasma Cells from Rhesus Macaques Using SIVmac239 SOSIP.664

Molecular Therapy. Methods & Clinical Development
Nuria Pedreño-LopezDavid I Watkins
September 20, 2020

Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop

Biochimica Et Biophysica Acta. General Subjects
Shubbir AhmedSweety Samal
September 25, 2020
Open Access

Virus-Like Particle Based-Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide

BioRxiv : the Preprint Server for Biology
A. T. MogusBryce Chackerian
September 25, 2020
Open Access

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against primary African isolates

BioRxiv : the Preprint Server for Biology
J. C. C. LorenziMichel C Nussenzweig
October 14, 2020

Evaluation of dried blood spot testing using the Abbott Alinity i

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Samantha J ShepherdRory N Gunson
October 2, 2020

The Presence of Antibody-Dependent Cell Cytotoxicity-Mediating Antibodies in Kaposi Sarcoma-Associated Herpesvirus-Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression

The Journal of Immunology : Official Journal of the American Association of Immunologists
Lisa K PoppeJohn T West

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.


Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

© 2020 Meta ULC. All rights reserved